Parkinson’s disease (PD) is a neurodegenerative disorder where alpha-synuclein plays a
central role in the death and dysfunction of neurons, both, in central, as well as in the …

Post-mortem analysis of brains from Parkinson's disease (PD) patients strongly supports
microglia activation and adaptive immunity as factors contributing to disease progression. Such …

Overexpression of human α-synuclein (α-syn) using recombinant adeno-associated viral (rAAV)
vectors provides a novel tool to study neurodegenerative processes seen in Parkinson's …

The role of neuroinflammation and the adaptive immune system in PD (Parkinson's disease)
has been the subject of intense investigation in recent years, both in animal models of …

The neuroprotective effect of the glial cell line-derived neurotrophic factor has been extensively
studied in various toxic models of Parkinson’s disease. However, it remains unclear …

The discovery of the central role played by the protein alpha-synuclein in Parkinson’s disease
and other Lewy body brain disorders has had a great relevance in the understanding of …

Recent research suggests a complex role for microglia not only in Parkinson’s disease but in
other disorders involving alpha-synuclein aggregation, such as multiple system atrophy. In …

The Na + /K + ‐ATPase1 alpha subunit 3 (ATP1α 3 ) is one of many essential components
that maintain the sodium and potassium gradients across the plasma membrane in animal …

The neuropathological hallmarks of Parkinson's disease ( PD ) are the degeneration and
death of dopamine‐producing neurons in the ventral midbrain, the widespread intraneuronal …

Lineage uncommitted pluripotent stem cells reside in the connective tissue of skeletal muscle.
The present study was carried out with pluripotent stem cells (PPSCs) isolated from 6‐…